Marketresearchnews

Wednesday, 7 October 2020

Stem Cell Assay Market 2020 Global Growth Insights, Trends, Size, Share And Forecast To 2023

Market Insights:

Stem Cells have been acknowledged for their promising potential toward the development of various cutting-edge treatments for a number of diseases. As such, stem cell assays have a rapidly growing market. Stem cell assays are essentially the techniques used for analyzing living cells by various parameters which ultimately help determine the biochemical and cellular functioning of cells. This has immense promise in drug development activities. Market Research Future's study of the market in its latest report has found that the global stem cell assay market is on track to register a highly optimistic outlook at a CAGR of 19.80% during the review period from 2017 to 2023.

Stem cell assays are a promising part of the biotechnology field, which is growing at a rapid pace. The prevalence of chronic and several lifestyle diseases has compelled the growth of drug development activities in an effort to develop effective treatments. Diseases such as cancer and diabetes are soaring at high rates and the demand for better, efficient and more affordable treatments are driving the market toward growth. Healthcare expenditure across the globe is increasing, and advancement in biotechnology and other medical technologies is highly encouraging of market growth. Government support toward drug development for chronic diseases has increased stem cell assay research.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5656

The market is held back by stringent government policies associated with approval of drugs as well as the high procedural cost of stem cell assays. Moreover, there is a lack of awareness regarding stem cell assays, and as a result, there is a dearth of skilled professionals which restrains market growth. However, growing healthcare activities and the increasing demand for treatment is likely to bring stem cell assays to the forefront and opportunities in the market are plentiful.

Market Segmentation:
Market structure is determined by its various significant sections which, in the report have been segmented on the basis of product, technology, assay, application, end-user, and region. Products in the market include flow cytometer, cell imaging systems, automated cell counter, kits, and others. The kits segment has been sub-segmented and includes umbilical cord stem cells, induced pluripotent stem cell kits, mesenchymal stem cell kits, and others.

The technology used in stem cell assays include microfluidics-based cell trap technologies, microfabricated assisted technology, and others

Assays in the market include cell identification assays, cell viability & toxicity assays, cell proliferation assays, cell apoptosis assays, and others.

Applications of stem cell assays can be found in orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and others.

End-users of stem cell assays include research organizations, academic institutes, biotechnology industries, academic institutes, and others.

Regional Analysis:
The Americas have captured the dominant share of the global market. The presence of North America in the region has had a significant impact on the regions market share possession. The rapid adoption of advanced medical technologies and the presence of a large patient population for various chronic diseases drive the Americas' market. Moreover, the regions healthcare expenditure is rising, and there are several leading players present in the North American sub-market.

Meanwhile, growing at the fastest pace is the Asia Pacific regional market. Gradually increasing awareness regarding advanced medical biotechnology is strongly impacting growth in the region. Several emerging economies in the region have a rapidly growing biotechnology sector which fuelling market growth. Findings by the Indian Brand Equity Foundation suggest that the Indian subcontinent has 2% of the global biotechnology share. Several opportunities in the region are expected to lead to market proliferation.

Key Players:
Prominent players included in MRFR’s report are Cell Biolabs, Inc., Thermo Fisher Scientific, Hemogenix, Merck KGaA, Promega Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cellular Dynamics International Inc., STEMCELL Technologies Inc., and others

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/stem-cell-assay-market-5656

Tuesday, 6 October 2020

World Fertility Services Market Top Key Players Shares, Revenue, Analysis And Forecasts To 2023

Market Highlights

Global Fertility Services Market is expected to register a CAGR of 8.99% during the forecast period, with a market value of USD 44,136.91 Million by 2025. Fertility services are procedures or treatments used to cure genetic and fertility issues and assist with conception. These services include assisted reproductive technology (ART) methods and drugs that help infertile couples in planning a family.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6281

Segment Analysis

The Global Fertility Services Market has been segmented by underlying cause and treatment.

Based on the underlying cause, the fertility services market has been segregated into female infertility and male infertility.

The Global Fertility Services Market, based on the treatment, has been segmented into ART and infertility drugs. The ART treatment has been further segmented into in-vitro fertilization (IVF), frozen embryo replacement (FER), artificial insemination, and others.

Regional Analysis

The Global Fertility Services Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Europe is expected to dominate the global fertility services market. This can be attributed to the lower fertility rate in the region and increasing IVF tourism in Spain. For instance, according to the European Society of Human Reproduction and Embryology (ESHRE), Spain is the preferred destination by foreigners for reproductive procedures, representing almost 40% of European fertility tourism, which is estimated to rise in the future. Moreover, easy reimbursement policies and increasing obesity cases are also expected to drive market growth.

The Americas market for fertility services is estimated to be the second-largest during the review period. The high number of ART procedures in the US is expected to boost the growth of the regional market. For instance, as per the data mentioned by the Centers for Disease Control and Prevention, in 2017, nearly 284,385 ART cycles were performed at 448 clinics in the US. Additionally, late pregnancies and the high adoption rate of IVF treatment are further fueling the market growth.

Asia-Pacific is estimated to be the fastest-growing market owing to the declining fertility rates in the region. According to the data suggested by the World Bank, the fertility rate in Japan decreased at a rate of 1.6 in 2016. Moreover, fertility disorders followed by favorable reimbursement scenario is also positively affecting the market growth.

The market in the Middle East & Africa is expected to witness steady growth due to the reduced ovarian reserve in women in the Middle Eastern countries.

Key Findings of the Study

The Global Fertility Services Market is estimated to reach USD 44,136.91 Million by 2025 at a CAGR of 8.99% during the assessment period

Europe accounted for the largest share of the global fertility services market due to the low fertility rate and increasing obesity rate

Based on the underlying cause, the female infertility segment accounted for the largest market share of 5% in 2018

Based on treatment type, the Assisted Reproductive Technology (ART) segment accounted for the largest market share of 21% in 2018

Key Players

MRFR recognizes the following companies as the Key Players in the Global Fertility Services Market— Merck KGaA (Germany), CooperSurgical, Inc. (US), Care Fertility (UK), Ferring B.V. (Switzerland), INVO Bioscience (US), Vitrolife (Sweden), Monash IVF Group (Australia), Cook (US), FUJIFILM Irvine Scientific (US), and Kitazato Corporation (Japan).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/fertility-services-market-6281

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Nurse Call System Market Likely Boost The Industry Revenue And Demand Till 2023

The global nurse call system market is expected to grow significantly over the forecast period. It is estimated that the global nurse call system market share is expected to register a CAGR 9.5 % during the forecast period from 2018 to 2023. Nurse call systems are aimed at alerting the nurses in case of medical emergency situations or when patients need care. These systems are also used to track a patient particularly in assisted living or old age centers or are used to give a signal of a probable situation in case of ambulatory services.

Numerous factors such as the growing geriatric population and the rising complexity of hospital operations are expected to drive the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5631

Moreover, favorable healthcare investments by the government and the rising demand for better technological advancements boost the growth of the market. However, stringent government regulation and the huge cost of installation may hamper the market growth during the assessment period.

Segmentation

The global nurse call system market has been segmented into type, technology, applications, and end-users.

The market, on the basis of type, has been segmented into nurse call buttons, nurse call integrated communication systems, nurse call mobile systems, nurse call intercoms, and others.

The market, by technology, has been segmented into wired systems and wireless systems.

The market, by applications, has been segmented into medical emergency, alarms, workflow management, and others.

The market, by end-users, has been segmented into hospitals & nursing homes, assisted living centers, ambulatory care centers, and others. Hospitals and nursing homes are expected to hold the largest market share in this segment owing to the rising number of public as well as private hospitals. Assisted living centers are expected to be the fastest-growing market owing to the increasing geriatric population and the rising need of such assisted living centers.

The market, by region, has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The nurse call system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European nurse call system market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The nurse call system market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nurse call system market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

Austco Communication Systems Pty Ltd., Honeywell International Inc., Hill-Rom Services Inc., Ascom, Johnson Controls., CSINC, AMETEK, Inc., STANLEY Healthcare, West-Com Nurse Call System, Inc, Azure Healthcare, Cornell Communications, Jeron Electronic Systems Inc., Vigil Health Solutions Inc., BEC Integrated Solutions, LLC and Systems Technologies are some of the key players in the global nurse call system market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/upcoming-reports/nurse-call-system-market-5631

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hypotension Treatment Market Forecasts By Industry Drivers, Regions Till 2023

The worldwide low blood pressure or hypotension market is driven by various factors. Some of these comprise rising hypotension cases, aged population, cardiovascular illnesses, & diabetics. Dehydration, endocrine disorders, and nerve issues can also cause hypotension, leading to further market growth. Low blood pressure patients often feel dizzy and weak, which is why, they are recommended several medicines to maintain stability and good health.

Teenagers and post-partum mothers are also impacted by hypotension. Moreover, sedentary & bad eating habits contribute to the development of lifestyle diseases, adding to the demand for better treatments. Medicines prescribed for hypotension can have serious side effects. However, these can be fought on account of proper guidance and patient-suitability. Awareness about hypotension and the demand for innovative cardiac instruments also propel market revenues.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5628

Developments across various technologies and entry of new companies should also boost market size in the forecast period. The 3 key factors that hamper the industry are the existence of alternative treatments, shortage of experts, and costly cardio diagnosis & treatments. The presence of cardiac & diabetic patients has increased stress on developing & developed nations. The hypotension treatment market is segmented on the basis of products, indications, applications, and regions.

Blood pressure instruments, blood pressure transducers, and sphygmomanometers constitute the products. Hypotension, cardiovascular disorders, and others form the indications. Application sectors comprise homecare, diagnostic centers, clinics, laboratories, hospitals, etc. Different regions across which the market is spread contain Asia Pacific, Americas, Europe, and the Middle East and Africa.

Geographical Details and Prominent Firms

“Americas” is the largest market, with its huge diabetic & coronary disease base driving its incomes. Asia Pacific should be observing the highest CAGR over the forecast period. Europe followed Americas in terms of the size. According to a study by MRFR (Market Research Future), the Middle East and Africa is expected to undergo steady expansion, due to the need for advanced therapeutic centers & diagnostic procedures.

Some of the eminent companies spending capital on the hypotension treatment industry are Shire plc, Hoffman-La Roche Limited, and Amgen, Inc. They make use of various strategies to gain shares and maintain competitiveness over other firms. These strategies consist of, but are not restricted to partnerships, acquisitions, mergers, and product launches.

Key Findings and Innovative Trends

The cardiovascular (hypotension) pipeline has assisted with tracking & recognizing new participants & their products. The said factor has widened the reach of hypotension treatments & helped make better decisions. A novel drug, Droxidopa, sold as Northera, was sanctioned to manage multiple-system atrophy, Parkinson’s disease, and pure autonomic failures. The authorization was done in view of 2 laboratory experiments.

In both these trials, patients consuming Droxidopa capsules for two weeks, benefitted with regards to feeling less dizzy & light-headed. Headache, nausea, and dizziness were some of the general side effects observed from these capsules. The drug would highlight the risk of hypertension in the horizontal position. Blood pressure in the horizontal position can be recorded before & during the therapy. The need for better hypotension medicines & therapies across end-user industries will also steer product developments in the near future.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hypotension-treatment-market-5628

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Eye Melanoma Market Key Manufactures Shares, Analysis And Forecasts Till 2023

Market Highlights

Increasing prevalence of the eye cancer, growing geriatric population, rising healthcare expenditures, and increasing research and development investments by the major players of the market are the major driver for the market growth. On the other hand factors such as lack of awareness, high diagnostics, and surgical procedures costs are projected to restrain the market growth during the estimated period. Laser iridotomy is estimated to cost around USD 1,068 to USD 1,188.

Segmentation

The global eye melanoma market is segmented on the basis of the site, diagnosis, treatment, and end user.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5570

On the basis of the site, the market is segmented into sclera, retina, uvea, and others. On the basis of the diagnosis, the market is categorized into eye exam, imaging, biopsy, and others. The eye exam segment is sub-segmented into ophthalmoscopy, slit-lamp biomicroscopy, and others. The imaging segmented is sub-segmented into ultrasound, fluorescein angiography, fundus autofluorescence, optical coherence tomography, and others. On the basis of the treatment, the market is segmented into radiation therapy, laser treatment, surgery, and others. The radiation therapy segment is sub-segmented into episcleral plaque therapy, external beam radiation therapy, and others. The surgery segment is sub-segmented into iridectomy, choroidectomy, enucleation, and others. On the basis of end users, the market is segmented into hospitals & clinics, academic institutes, and others.

Regional Analysis

America dominates the global eye melanoma market. The presence of a well-developed healthcare sector, huge patient population, changing lifestyle, and increasing health care expenditure are major drivers of the Americas market. Europe is the second leading region in the global eye melanoma market due to increasing availability of funds for research, well-developed healthcare sector, huge patient and growing geriatric population. The European region is bifurcated into Western Europe and Eastern Europe. Western Europe leads the market due to the presence of the developed economies, for instance, the U.K, France, and Italy. The Asia Pacific is the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, and rising healthcare expenditure. The Middle East & Africa owns the least share of the global eye melanoma market due to the presence of poor economies and stringent government policies, especially in the African region. The Middle East holds a majority of the market due to a well-developed healthcare sector and huge healthcare expenditure by economies like Dubai, Kuwait, Dubai, and others.

Key Players

The key players for the global eye melanoma market are Castle Biosciences, Inc. (U.S.), GENERAL ELECTRIC (U.S.), Koninklijke Philips N.V. (The Netherlands), TOSHIBA CORPORATION (Japan), Siemens AG (Germany), Analogic Corporation (U.S.), Optovue, Incorporated (U.S.), NOVADAQ Technologies Inc. (Canada), Agfa-Gevaert Group (Belgium), ZEISS (Germany), and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/eye-melanoma-market-5570

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cardiac Pacemaker Market Cagr Growth Expected To Be Linear To The Skyrocketing Rise ! Predicted By 2023

Overview of the global cardiac pacemaker market

According to report by Market Research Future (MRFR), the global cardiac pacemaker market is set to register a CAGR of approximately 7.9% during the forecast period (2017-2023).

Drivers and Restraints

MRFR’s market study identifies the growing prevalence of cardiovascular disorders to be one of the main growth drivers for the cardiac pacemaker market. Cardiovascular disorder is one of the main causes of death in developed and developing nations. Factors such as high blood pressure, lack of physical exercise, obesity, hereditary, diabetes and growing geriatric population are mainly responsible for causing cardiovascular diseases in individuals. This is where a cardiac pacemaker comes in, which is used to regulate the heartbeat frequency that is reduced by cardiovascular disorder.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2025

Various supportive government initiatives coupled with non-government organizations funding has also been instrumental in the phenomenal market growth over the past couple of years. For instance, the University of Michigan has entered into a partnership with World Medical Relief to develop the My Heart, Your Heart pacemaker program. It entails using a previously used pacemaker which is tested, certified and reconditioned before being sent to help needy people in other economies.

However, high cost of treatment is predicted to restrain the growth of the market over the forecast period. On the other hand, cardiac pacemaker manufacturers are continuously integrating new and innovative technologies to improve the efficiency and output of the pacemakers. For instance, Medtronic has developed new products like leadless pacemaker and rate-responsive pacemaker with enhanced features, effectivity, and functionality.

Market Segmentation

The global cardiac pacemaker market is segmented based on type, technology, application, and end users.

By type, the market is segmented into implantable, external cardiac pacemaker, and others. Implantable cardiac pacemakers are small devices that are placed inside the chest or abdomen to control abnormal heart rhythms. This means the patient has more energy and less shortness of breath. Thus, the segment of implantable pacemaker is surging at a higher rate than other sub-segments.

By technology, the market is segmented into biventricular, single-chambered, dual-chambered, and others. Biventricular devices are expected to gain lucrative share over the review period. These devices consist of two or three leads and are used in patients that present a lack of synchronization between contractions of the left and right ventricles, a condition known as ventricular desynchrony.

By application, the market is segmented into arrhythmias, congestive heart failure, and others. The arrhythmias segment is sub-segmented into tachycardia, bradycardia, and others. with increasing incidences of arrhythmias across the globe, the application of cardiac pacemaker for arrhythmias cases is high in the global market. By end-user, the market is segmented into hospitals, cardiac care centers, medical institutes, and others.

Regional Analysis

The global cardiac pacemaker market is segmented into regions of the Americas, Europe, Asia Pacific and the Middle East & Africa.

Globally, the Americas lead the global cardiac pacemaker market on account of the well-developed healthcare sector and massive patient population. Additionally, changing lifestyle, increasing healthcare expenditure, and growing geriatric population fosters the market growth in the Americas. Moreover, the presence of the developed economies such as the United States (U.S) and Canada within the region triggers the market growth as well.

Europe is the second largest market across the globe. Availability of funds for research, growing patient population, increasing healthcare expenditures, sophisticated healthcare sector and government support for research & development are exhibited to buoy the market growth during the conjectured period.

Asia Pacific is the fastest growing region, MRFR asserts that it is due to the presence of huge patient population, continuously developing economies such as India and China. These countries have increasing healthcare expenditures and growing healthcare sector along with favorable government policies like relaxation in customs and excise duty.

Lastly, the Middle East & Africa holds the least market share on the back of poor economy and strict government policies in the African region. A major portion of the market in the Middle East & Africa is held by the Middle East owing to the well-developed healthcare sector and massive healthcare expenditure by the economies like Kuwait, Saudi Arabia, Dubai, and Qatar.

Competitive Dashboard

The prominent players at the forefront of the market are LEPU MEDICAL (U.K), SORIN Group (Europe), MEDICO S.p.A. (Europe), Medtronic (U.S.), Abbott. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK (Germany), OSCOR Inc. (U.S.), and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/cardiac-pacemaker-market-2025

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Moebius syndrome Market 2020 – Leading Manufactures, Regions, Drivers, Analysis And Forecasts Till 2023

Market Highlights

Moebius syndrome is a rare congenital condition that is associated with abnormalities of the facial nerves. The major symptoms of Moebius syndrome are dental problems, difficulties with speech and frequent drooling, high palate, Poland’s syndrome, irritated and dry eyes, strabismus, and others.

A number of factors such as growing awareness, technological advancements, unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are propelling the growth of the global Moebius syndrome market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5407

However, infections and injuries caused by surgical devices, complications associated with the treatments and poor healthcare system in low and middle-income countries may hamper the growth of the market over the review period.

It is estimated that the Moebius syndrome market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023.

Regional Analysis

The Americas dominate the Moebius syndrome market owing to the rising awareness among people, and high healthcare expenditure. According to the Centers for Disease Control (CDC) and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and the hospital care accounted for a share of 32.3%.

Europe holds the second position in the Moebius syndrome market. It is expected that the support provided by the government authorities for research & development and initiatives taken to improve the reimbursement policies in healthcare is likely to drive the European market.

Asia Pacific is the fastest growing Moebius syndrome market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare, in the years 2015-2016, the total health expenditure in Australia was USD 170.4 billion, which is recorded to be 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the lowest share of the global market due to lack of technical knowledge and poor medical facilities.

Segmentation

The global Moebius syndrome market is segmented on the basis of type, treatment, and end user.

On the basis of the type, the market is classified as Group I, Group II, Group III, and Group IV.

On the basis of the treatment, the market is classified as surgery, temporalis transfer, parotidectomy, physical therapy, occupational therapy, speech therapy, splints, prosthesis, braces, and others. The surgery segment is further classified into eyelid surgery, ponseti method, hand surgery, tracheotomy, and others.

On the basis of the end user, the market is segmented into medical device companies, hospitals & clinics, academic & research institutes, and others.

Key Players

Some of key the players in the global Moebius syndrome market are Alcon Laboratories, Inc, All Vascular, Pty Ltd., Aspen Surgical Products, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Conmed Corporation, Gray Surgical, Johnson & Johnson Services, Inc., Medtronic, Olympus Corporation, Smith & Nephew plc, TransEnterix Surgical, Inc., Zimmer Biomet Holdings, Inc. and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/moebius-syndrome-market-5407

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com